Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Davis, Mellar P.
Dickerson, E. Duke
Pappagallo, Marco
Benedetti, Costantino
Grauer, Phyllis A.
and
Lycan, Jeff
2001.
Mirtazepine: Heir apparent to amitriptyline?.
American Journal of Hospice and Palliative Medicine®,
Vol. 18,
Issue. 1,
p.
42.
Shapiro, David A
and
Roth, Bryan L
2001.
Insights into the structure and function of 5-HT2familyserotonin receptors reveal novel strategies for therapeutic target development.
Expert Opinion on Therapeutic Targets,
Vol. 5,
Issue. 6,
p.
685.
Anttila, Sami A. K.
and
Leinonen, Esa V. J.
2001.
A Review of the Pharmacological and Clinical Profile of Mirtazapine.
CNS Drug Reviews,
Vol. 7,
Issue. 3,
p.
249.
Kethini, Thejaswarup
Alderman, Christopher P
and
Doecke, Christopher J
2004.
Mirtazapine‐Associated Rapid Weight Gain and Decreased Physical Activity.
Journal of Pharmacy Practice and Research,
Vol. 34,
Issue. 4,
p.
308.
Kennedy, Gary J
and
Marcus, Paula
2005.
Use of Antidepressants in Older Patients with Co-Morbid Medical Conditions.
Drugs & Aging,
Vol. 22,
Issue. 4,
p.
273.
2015.
Arzneimitteltherapie in der Palliativmedizin.
p.
229.
2018.
Arzneimitteltherapie in der Palliativmedizin.
p.
253.
2022.
Arzneimitteltherapie in der Palliativmedizin.
p.
301.
eLetters
No eLetters have been published for this article.